Advertisement
BD Bioscience
BD Bioscience

The Scientist

» drug development, immunology and neuroscience

Most Recent

image: More Evidence of Alzheimer’s Transmission

More Evidence of Alzheimer’s Transmission

By | January 27, 2016

Examining the brains of seven patients who died of the prion disease called Creutzfeldt–Jakob, researchers find signs of Alzheimer’s pathology. 

1 Comment

image: Cross-Reactive Ebola Antibodies

Cross-Reactive Ebola Antibodies

By | January 21, 2016

Human monoclonal antibodies induced during Ebola infection are able to neutralize related viral species, scientists show. 

0 Comments

image: Processing Faces

Processing Faces

By | January 21, 2016

Other people’s faces are mapped onto our brains.

0 Comments

image: Planning for the Next Ebola Outbreak

Planning for the Next Ebola Outbreak

By | January 20, 2016

A public-health nonprofit and an international drugmaker team up to stockpile hundreds of thousands of doses of a promising vaccine and to speed along the approval process.

0 Comments

image: Cocaine Induces Neuronal Autophagy

Cocaine Induces Neuronal Autophagy

By | January 19, 2016

A new study supports the idea that cocaine triggers brain cells to eat themselves and suggests a possible antidote.

2 Comments

image: Cord Blood Cells Foretell Food Allergy

Cord Blood Cells Foretell Food Allergy

By | January 13, 2016

Scientists link an immune phenotype present at birth to the development of food allergies a year later.

2 Comments

image: How Blasts Affect the Brain

How Blasts Affect the Brain

By | January 13, 2016

Repeated exposure to explosions can damage the cerebellum in combat veterans and mouse models alike.

0 Comments

image: Shire to Buy Baxalta for $32 Billion

Shire to Buy Baxalta for $32 Billion

By | January 12, 2016

The Dublin-based pharma giant is set to acquire Baxalta, an Illinois-based Baxter spinoff, expanding its rare disease drug portfolio.

0 Comments

image: Brain-Training Firm, FTC Settle

Brain-Training Firm, FTC Settle

By | January 6, 2016

San Francisco-based Lumos Labs, creator of the brain-training program Lumosity, will pay $2 million to settle deceptive-advertising charges raised by the US Federal Trade Commission.

0 Comments

image: Molecular Fingerprint Predicts Flu Shot Response

Molecular Fingerprint Predicts Flu Shot Response

By | January 4, 2016

A gene-expression signature correlates with a person’s likelihood of experiencing adverse events after receiving a seasonal flu vaccine, scientists show. 

0 Comments

Advertisement
LabX
LabX

Popular Now

  1. First Data from Anti-Aging Gene Therapy
  2. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

  3. Brain Keeps Watch During Sleep
  4. Locating Language within the Brain
Advertisement
Advertisement
LI-COR Biosciences
LI-COR Biosciences